Abstract: Extract obtainable by extraction from Phaseolus sp. with mixtures of ethanol and water, characterised by an ?-amylase inhibitor content in between 1,000 and 1,600 USP/mg (HPLC titre between 6 and 14% w/w) and a phytohaemagglutinin content in between 8,000 and 30,000 HAU/g, and a process for its preparation.

Abstract: Extract obtainable by extraction from Phaseolus sp. with mixtures of ethanol and water, characterised by an ?-amylase inhibitor content in between 1,000 and 1,600 USP/mg (HPLC titre between 6 and 14% w/w) and a phytohaemagglutinin content in between 8,000 and 30,000 HAU/g, and a process for its preparation.

Abstract: Extract obtainable by extraction from Phaseolus sp. with mixtures of ethanol and water, characterised by an ?-amylase inhibitor content in between 1,000 and 1,600 USP/mg (HPLC titre between 6 and 14% w/w) and a phytohaemagglutinin content in between 8,000 and 30,000 HAU/g, and a process for its preparation.

Abstract: Extracts obtainable by extraction from Phaseolus sp. with aqueous solutions, characterised by an ?-amylase inhibitor content with an activity equal to or greater than 1,800 USP/mg (HPLC titre equal to or greater than 15% w/w) and a phytohaemagglutinin content of between 1,500 and 6,000 HAU/g, and a process for its preparation.

Abstract: The invention relates to a process for the preparation of a vanilla extract, which process consists in subjecting vanilla green beans to accelerated browning followed by extractive/enzymatic treatment.

Abstract: A process is provided for producing a purified extract from Ginkgo biloba leaves by solvent extraction with selected solvents. In the process, a crude or partially purified extract is subjected to solvent extraction with a solvent comprising toluene and n-butanol. Pharmaceutical compositions comprising dimeric flavones and/or polyphenols are also described.

Abstract: A process is provided for producing a purified extract from Ginkgo biloba leaves by solvent extraction with selected solvents. In the process, a crude or partially purified extract is subjected to solvent extraction with a solvent comprising toluene and n-butanol. Pharmaceutical. compositions comprising dimeric flavones and/or polyphenols are also described.

Abstract: Molding process of articles having color contrast areas on the surface comprising the coating of the surface or of part of the surface of the mold with a colored composition polymerized before filling the mold with a polymerizable fluid composition wherein the colored composition is a fluid, stable and redispersable dispersion, comprising:a) a solvent consisting essentially of polymerizable liquid monomers, optionally in admixture with a non-polymerizable volatile organic solvent;b) from 0.1 to 10% by weight of a color composition as inorganic pigment or from 0.0001 to 1% by weight of an organic pigment or organic dye;c) from 1 to 30% by weight of an unsaturated polyester resin soluble in the solvent a),the component a) being at least 20% by weight of the total composition.

Abstract: An extract enriched in procyanidol oligomers almost free from monomers is obtained by subjecting a crude vegetable extract, for instance from Vitis vinifera, to ultrafiltration on membranes of cut-off from 3,000 to 600, or to a selective extraction with ethers, or esters or mixtures of ethyl acetate and aromatic hydrocarbons.